CDKN2A and neoplasm: For the G8 groups, the 10‐biomarker panel included the blood immune/senescence markers: miR‐9, p16INK4a, Gal‐9, CD3+CD16+, CD8+CD57+, CD8+CD27−CD28−, CD4+CD27−CD28− cells and CD4+CD57+ cells together with the tumor immune infiltrate markers: whole tumor proportion and tumor centre density of FOXP3+ cells.